New York, NY – December 11, 2018 Kali, Inc. (USOTC: KALY) today is one of the top 50 most actively traded stocks on OTCMarkets along with Hemp, Inc. (HEMP), North American Cannabis Holdings, Inc. (USMJ) and Hemp America, Inc. (HMPQ). The KALY PPS moved up 30% yesterday on over $100,000 of trading volume and the PPS is up again today. KALY continues to be rated VERY BULLISH by Stockta.com. KALY is trading above its 200, 100, and 50 Day Moving Averages. Just over 30 days ago, in the midst of the Canadian recreational marijuana legalization market surge, KALY hit a high of $0.009 pushing the penny boundary. Since then, KALY has acquired a patented cannabis extraction process and the associated pharmaceutical research that came with the patent, additionally announcing a $300,000 contract to extract hemp-derived CBD, and plans to introduce its own hemp-derived CBD gum before the end of the year. The company has recently begun updating the new post patent acquisition information on OTCMarkets and has indicated its intentions to have all public information on the OTCMarkets updated soon. With the newly acquired patented cannabis extraction asset, a signed $300,000 contract, the production of its own CBD infused product underway, and updated public disclosures, all combined with the pending legalization of hemp farming included in the 2018 Farm Act signed by Senator Mitch McConnell yesterday (using a hemp pen), KALY looks poised to break through the $0.01 before the end of the year.
90 days ago, KALY’s PPS was lingering on low volume between $0.0003 by $0.0004. In mid-October, KALY trading came to life when the company announced an LOI to acquire the patented cannabis extraction process. All total, in the last 90 days, the trading volume has turned over the issued and outstanding almost five times at a weighted average PPS of just under $0.003 reaching a high of $0.009 on November 1st. Since the market cooling off following the Canadian recreational marijuana legalization market surge, KALY trading has hovered around the $0.003 90 day weighted average. Yesterday, after KALY announced its $300,000 hemp-derived CBD extraction contract, the PPS started to move north. As the cannabis market heats up in conjunction with the U.S. anticipated legalization of hemp farming as drafted into the pending 2018 Farm Act, KALY is staged, both business development wise and stock technical wise, to realize a substantial PPS climb.
Learn more at www.kali-extracts.com.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.